At a glance

Estimated value Not provided
Submission deadline Not provided
Published signals 0/100 No published signals
Lots 1 lot Awards 1 award
Awarded suppliers 1 awarded supplier
Documents 0 documents Notice history 2 notices
Received offers 1 offer

Published screening signals

Score from published signals 0/100
No published signals 0 published signals

These screening signals are generated by automated algorithms from imported procurement data. Data may be incomplete, and false positives are possible. A signal is a lead for further research, not proof of wrongdoing.

This tender has been screened; no signals have been published.

Procurement facts

Identification

Procurement id
2e0f72f3-0853-46c3-9c8e-e15148dc64bc
Procedure
Negotiated procedure without prior call
Legal basis
Public Procurement Law — below the EU threshold
Main nature
Supplies
Main CPV
33000000-0

Values and statistics

Estimated value
Not provided
Contract value
9,000.00 EUR
Received offers
1
Lots
1 lot

Authority

Registration
40003951628
Country
LVA

Awards

1 award Export awards CSV
Awards
Supplier Lot and contract Value Dates
Sabiedrība ar ierobežotu atbildību Signamed Lot 1 Doxorubicin 2 mg/ml koncentrāts infūziju šķīduma pagatavošanai N1 50 mg 25 ml Pharmagen CZ Contract B2-2024/288 9,000.00 EUR Concluded 2024-04-24

Lots

1 lot
Lots
Lot Place and duration Estimated value Result
Lot 1 Doxorubicin 2 mg/ml koncentrāts infūziju šķīduma pagatavošanai N1 50 mg 25 ml Pharmagen CZ Rīga, LVA Duration unknown to 2024-05-23 Not provided 1 offers Winner selected Decision 2024-04-16 No EU funding recorded

Documents

0 documents

No document links available.

Notice history

2 notices
Notice history
Notice Type and form Date
e9df22b4-db83-4b4b-b494-01da10d315f1 pil-award Form result 2024-04-25
a93fd57d-657e-4371-9681-5f572ff14c0d pil-award Form result 2024-04-24